Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Subcutaneous Recombinant Human Erythropoietin in Healthy Males
NCT04954989Phase 1Not yet recruiting
- Sponsor
- Megalabs
- Start
- Oct 2024
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of erythropoietin in anemia (2 arms), sponsored by Megalabs. Primary endpoints: Area Under the Concentration-Time Curve from time zero to infinity at 14 days, Maximum Plasma Concentration at 14 days and 2 more. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
erythropoietin
03
Conditions
anemia
Beyond the preview
Go deeper on NCT04954989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04954989.